Cargando…
MiniCAFE, a CRISPR/Cas9-based compact and potent transcriptional activator, elicits gene expression in vivo
CRISPR-mediated gene activation (CRISPRa) is a promising therapeutic gene editing strategy without inducing DNA double-strand breaks (DSBs). However, in vivo implementation of these CRISPRa systems remains a challenge. Here, we report a compact and robust miniCas9 activator (termed miniCAFE) for in...
Autores principales: | Zhang, Xin, Lv, Sihan, Luo, Zhenhuan, Hu, Yongfei, Peng, Xin, Lv, Jie, Zhao, Shanshan, Feng, Jianqi, Huang, Guanjie, Wan, Qin-Li, Liu, Jun, Huang, Hongxin, Luan, Bing, Wang, Dong, Zhao, Xiaoyang, Lin, Ying, Zhou, Qinghua, Zhang, Zhen-Ning, Rong, Zhili |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053112/ https://www.ncbi.nlm.nih.gov/pubmed/33751124 http://dx.doi.org/10.1093/nar/gkab174 |
Ejemplares similares
-
Erratum for article ‘MiniCAFE, a CRISPR/Cas9-based compact and potent transcriptional activator, elicits gene expression invivo’
por: Zhang, Xin, et al.
Publicado: (2021) -
Phase-separated DropCRISPRa platform for efficient gene activation in mammalian cells and mice
por: Ma, Shufeng, et al.
Publicado: (2023) -
Enhancing site-specific DNA integration by a Cas9 nuclease fused with a DNA donor-binding domain
por: Ma, Shufeng, et al.
Publicado: (2020) -
Tag-seq: a convenient and scalable method for genome-wide specificity assessment of CRISPR/Cas nucleases
por: Huang, Hongxin, et al.
Publicado: (2021) -
Engineered Cas12a-Plus nuclease enables gene editing with enhanced activity and specificity
por: Huang, Hongxin, et al.
Publicado: (2022)